thebench.bio #1 Ecosystem for the Bio-Tech Industry

Software Daily Summary

Software Daily Summary: What Happened on October 30, 2026

Brox.AI builds a physician panel for digital-clone research

A biopharma essay argues AI could add drug candidates faster than the industry can improve R&D productivity.

  • Updated
  • Read from 3 articles, 2 publications
  • P

Today in brief

Brox.AI says it has recruited 80 US physicians who prescribe a specialized pancreatic cancer therapy for a digital-clone research panel.12 A LifeSciVC essay predicts AI will weaken industry-wide R&D productivity over the next three to five years, before improving it over the longer term.3

Also worth knowing

  • P

    CEO Hamish Brocklebank said physicians can query their clones through Brox.AI’s Melivora and request removal of their data. He said building a high-quality clone takes four to five hours, and Brox.AI can pay physicians $2,000 or more per hour, compared with about $500 at a typical research firm.12

  • The essay’s author argues AI may intensify competition around established drug targets. Better medicines and any gains in development productivity could take years to assess.3